Steven H Stein, EVP & Chief Medical Officer at Incyte, holds 90.01K shares in Incyte (Ticker: INCY), holds ― shares in Kura Oncology (Ticker: KURA), holds ― shares in Theseus Pharmaceuticals (Ticker: THRX). Most recently, Steven H Stein Sold ― shares of Incyte on Aug 14, 2024 for an estimated value of 703.79K.
What is the percentage of profitable transactions made by Steven H Stein?
The percentage of profitable transactions made by Steven H Stein is 33%.
What is the average return per transaction made by Steven H Stein?
The average return per transaction made by Steven H Stein is -8.70%.
What stocks does Steven H Stein hold?
Steven H Stein holds: INCY, KURA, THRX, RPTX stocks.
What was Steven H Stein’s latest transaction?
Steven H Stein latest transaction was an Informative Sell of $703.79K.
What was Steven H Stein's most profitable transaction?
Steven H Stein’s most profitable transaction was an Informative Sell of INCY stock on August 3, 2023. The return on the trade was 0.70%.
What is Steven H Stein's role in Incyte?
Steven H Stein's role in Incyte is EVP & Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.